Fsrh contraception guidelines progesterone. Faculty of Sexual & Reproductive Healthcare (FSRH).
Fsrh contraception guidelines progesterone Contraception after Pregnancy aims to guide healthcare professionals to inform and support the women in their care to make planned choices about future pregnancies and improve maternal and child outcomes through optimum spacing between children. Dopamine agonists are not known to interact with hormonal contraceptives and no interaction is listed in the BNF2 3,4,12 or SPC for these products. UK MEC; UK Medical Eligibility Criteria for Contraceptive Use (UK MEC) Summary Sheets (2016, amended Sep 2019) FREE; Progestogen-only Injectable Contraception (Dec 2014, amended Jul 2023) FREE; Progestogen-only Implant (Feb 2021, amended Jul 2023) We are the leader in the field of sexual and reproductive healthcare, and the voice for professionals working in this area. 3 Intrauterine methods 5 5. 1 Progestogen-only pills 10 6. We believe that access to sexual and reproductive healthcare is a fundamental We are the leader in the field of sexual and reproductive healthcare, and the voice for professionals working in this area. Open here: FSRH Clinical Guideline: Progestogen-only Pills. 2 Progestogen-only contraceptives; How it works. 4 Sterilisation 6 6 Contraceptive Decision-making and Special Measures for Women with 7 Cardiac Disease 6. 4 Levonorgestrel-releasing intrauterine system 12 References 13 Appendix 1: Development of CEU Guidance 16 6. Females using combined hormonal contraceptive patches, vaginal rings, or oral tablets who require enzyme-inducing drugs should always be advised to change to a reliable contraceptive method that is unaffected by enzyme-inducers, such as a copper IUD, a . Data relating to newer COC containing estradiol are very Search FSRH website. ing emergency contraception),2 and its 2016 quality standard on contraception includes the quality statement “Women asking for emergency contraception are told that an intrauterine device is more effective than an oral method”. These recommendations are largely based on the Faculty of Sexual and Reproductive Healthcare (FSRH) guidelines Progestogen-only pills (March 2015, amended April 2019) [FSRH, 2019b] and Contraception for women aged over 40 years (August 2017, guidance-contraception for- -women-aged-over-40-years-2017/ Details of changes to original guidance document The CEU has updated this guidance (which was first published in August 2017). Offer a Cu-IUD (unaffected by FSRH Guideline Emergency Contraception March 2017 (Amended December 2017) | FSRH . The guideline is IMP = Progestogen-only implant; DMPA = Progestogen-only injectable: depot medroxyprogesterone acetate; POP = Progestogen-only pill; CHC = Combined hormonal contraception: of a method requires expert clinical judgement and/or referral to a specialist contraceptive provider, since use of the 6. This guidance includes evidence-based recommendations and good practice points for healthcare professionals or services who provides contraceptive care. Www. In addition to this FSRH CEU guidance document, it is recommended contraceptive progestogen implants, and oral emergency contraception. Published progestogen-only pill postural orthostatic tachycardia syndrome discontinuation of intrauterine contraception or the progestogen-only implant. Prolactinoma. B Injection site reactions appear to be more common with use of subcutaneous (SC) DMPA than with use of intramuscular (IM) DMPA. This treatment summary topic describes contraceptives, interactions. About us This page contains information, links and resources for prescribing of contraceptives Back to Prescribing Guidelines by Clinical Area When prescribing contraception, information The United Kingdom’s Faculty of Sexual and Reproductive Healthcare (FSRH) guideline, Contraception After Pregnancy,1 forms the basis for New Zealand Aotearoa’s guidance on the use of contraception after pregnancy. 1019969 FSRH Guideline (January 2017) Contraception After Pregnancy (Revision due by January 2022) Purpose and scope C Women should be advised that intrauterine contraception (IUC) and progestogen-only implant (IMP) can be inserted immediately after delivery. Title Emergency Contraception March 2017 (Amended December 2017) contraception, progestogen-only pill and progestogen-only implant has been revised to: EC is indicated if there is UPSI or barrier failure during, or in the 28 days For example, progestogen-only contraception might reduce the efficacy of ulipristal acetate emergency contraception (UPA-EC) because of opposing action on progesterone receptors or vice versa. VTE or a past history or predisposition to venous thrombosis). micronised progesterone 300 mg for 12 days a Progestogen-only contraceptives POPs are suitable when oestrogens are contra-indicated (e. Immediate use of LARC is associated with a FSRH Clinical Guideline: Contraception after Pregnancy 1 Jan 2017 Kaye Wellings, Prof, FRCOG, Kyle G Jones et al. fsrh. To cite this guideline: FSRH Guideline (February 2021) Progestogen-only Implant. org FSRH guideline summary: Progesterone only pill for MRCOG Part 2 revision the FSRH) to assist them in the production of this guideline, Contraception After Pregnancy (2017). Combined oral contraception (COC) The recommendations in the UKMEC refer to low-dose combined oral contraception (COC) containing <35 μg ethinylestradiol (EE) combined with a progestogen. FSRH guidance on the IMP,1 progestogen-only injectable2 and POP3 is available on the FSRH website. The guidance is intended for use by health professionals providing contraceptive services to young The clinical effectiveness unit of the FSRH have published a variety of evidence based guidelines on contraceptive choices along with a guide to using their guidelines. 3. Offer a Cu-IUD (unaffected by This FSRH Guidance provides key information and good practice points for health professionals on the provision of informed and supportive contraceptive care to individuals who have or have had breast cancer. For further information on progestogen-only injections including dosing interval of repeat injections and management of side-effects, see FSRH guidance: Progestogen-only Injectable Contraception (see Useful resources). Contraceptive effectiveness of the progestogen-only pill (POP) relies on correct use. The copper IUD (coil) is the most effective method of emergency contraception and is not affected by diarrhoea and vomiting. Contraception for trans people assigned male at birth Trans women and non-binary (assigned male We are the leader in the field of sexual and reproductive healthcare, and the voice for professionals working in this area. If a guideline is updated, the FSRH replace the version on its website and the BMJ Sexual & Reproductive Health (BMJ SRH) journal will ensure old versions of guidelines will clearly signpost the newer version. FSRH Guideline Emergency Contraception March 2017 (updated December 2017) | FSRH . The UKMEC category for use of progestogen-only injectable contraception by women at high risk of acquiring HIV has been revised from UKMEC2 (benefits of use generally outweigh risks) to UKMEC1 (CEU) of the FSRH and involved a guideline development group (GDG) consisting of 19 members (see Appendix 1 for the UKMEC 2 Summary of recommendations • Information about contraception after childbirth should be offered in the antenatal period to support informed decision-making and facilitate provision of contraception by maternity services. The UKMEC category for use of progestogen-only injectable contraception by women at high risk of acquiring HIV has been revised from UKMEC2 (benefits of use generally outweigh risks) to UKMEC1 The UKMEC update was led by the Clinical Efectiveness Unit (CEU) of the FSRH and involved a guideline development group (GDG) consisting of 19 For further information on progestogen-only injections including dosing interval of repeat injections and management of side-effects, see FSRH guidance: Progestogen-only Injectable Contraception (see Useful resources). 3 The more detailed FSRH guideline is there-fore a much-needed resource for health-care professionals. Source: FSRH We are the leader in the field of sexual and reproductive healthcare, and the voice for professionals working in this area. Recommendations on when to start progestogen-only contraception after pregnancy, miscarriage, or termination of pregnancy have been updated in line contraceptive agents; female; hormonal contraception; long-acting reversible contraception; The UK Faculty of Sexual & Reproductive Healthcare (FSRH) has updated its 2014 guideline1 on the progestogen-only implant, reexamining old FSRH Guideline Emergency Contraception March 2017 (updated December 2017) | FSRH . B One of the most commonly used contraceptive methods in the UK is the combined oral contraceptive pill (COC). Toggle navigation. As a multidisciplinary professional membership organisation, we set clinical guidance and standards, provide This document updates previous Faculty of Sexual & Reproductive Healthcare (FSRH) guidance and aims to summarise the available evidence and expert opinion on combined hormonal contraception (CHC). Information covered includes who can use FSRH guidance states that contraception is not required after the age of 55 years as conception is exceptionally rare13. Details of the methods used by the Clinical Effectiveness Unit (CEU) in developing this guideline and a list of contributors are outlined in Appendix 1. traditional POP is considered missed if it is taken more than 3 hours late, a desogestrel (DSG) POP if it is taken more than 12 hours late, and a drospirenone (DRSP) POP if more than 24 hours late. The contraceptive efficacy of combined hormonal contraceptive and progestogen-only contraceptives will not be affected by use of such treatments. This guidance provides evidence-based recommendations and good practice points for health professionals on the management of problematic bleeding in women using hormonal contraception currently available in the UK. 4. For further details refer to FSRH Guidance (December 2014): Progestogen-only Injectables. The information on drug interactions has been updated in line with the Faculty of Sexual and Reproductive Healthcare (FSRH) guideline Drug interactions with hormonal contraception [FSRH, 2017a]. 4 Combined hormonal contraceptives (CHCs) contain estrogen and progestogen and there are currently three methods available in the UK: Combined oral contraceptive pill (COC) Combined transdermal patch (CTP) Combined vaginal ring (CVR). The guidance is intended for use by healthcare professionals working in SRH and can also be used by women using CHC. 2. To cite FSRH Guideline (March 2023) Intrauterine Contraception. This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables (depot medroxyprogesterone acetate This guideline will consider the progestogen-only contraceptive pills (POPs) available in the UK, namely desogestrel (DSG) 75 μg, drospirenone (DRSP) 4 mg (soon to be available in the UK) and the ‘traditional’ POPs The Faculty of Sexual and Reproductive Healthcare (FSRH) have published clinical guidance on the use of progesterone-only contraceptive pills in the UK. I need emergency contraception and I’m taking a GLP-1 agonist; will it work? We don’t know yet if oral emergency contraception is affected by GLP-1 agonists. 2 Progestogen-only contraception 10 6. If you require emergency contraception, please tell Contraceptive Agents, Female / therapeutic use Desogestrel / therapeutic use* Female Guidelines as Topic Humans Prostheses and Implants / trends* FSRH Guideline (February 2021) Progestogen-only Implant We are the leader in the field of sexual and reproductive healthcare, and the voice for professionals working in this area. 1 Combined hormonal contraception 9 6. oral or vaginal progestogen in this context, women who require high dose est rogen intake should consider having their progestogen dose increased to ensure adequate endometria l protection (e. 2 the same content. As a multidisciplinary professional membership organisation, we set clinical guidance and standards, provide We are the leader in the field of sexual and reproductive healthcare, and the voice for professionals working in this area. CEU GUIDANCE iv ©FSRH 2014 C Women who gain more than 5% of their baseline body weight in the first 6 months of DMPA use are likely to experience continued weight gain. Medroxyprogesterone acetate. Method specific recommendations relating to contraception are included in other FSRH guidelines. 72. Individuals should be advised that there can be a delay of up to 1 year in the return FSRH Guidance (March 2010) Contraceptive Choices for Young People (Update due by March 2015) Purpose and Scope We are the leader in the field of sexual and reproductive healthcare, and the voice for professionals working in this area. References 1. Registered in England No. • After childbirth, effective contraception should be discussed and offered prior to discharge from maternity services. The digital version can be accessed from the BMJ SRH website: FSRH Guideline (January 2019, We are the leader in the field of sexual and reproductive healthcare, and the voice for professionals working in this area. 3 Progestogen-only implants 11 6. 1 Combined hormonal contraception 4 5. The recommendations included should be used to guide clinical practice but are not intended to serve alone as a standard of medical care or to replace clinical judgement in the management of individual cases. This guidance includes evidence The FSRH guideline provides comprehensive information on the use of progestogen-only pills. Faculty of Sexual & Reproductive Healthcare (FSRH). org This guideline provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only contraceptive pills. It is intended for any health care professional or health service providing contraceptive care in the UK. 1 Non-hormonal contraception Non-hormonal contraception should be considered first-line Recommended actions after incorrect use of Combined Hormonal Contraception (e. This is particularly true during use of teratogenic contraception; IMP, progestogen-only implant; LNG-IUS, levonorgestrel-releasing intrauterine system; POP, progestogenonly This guideline is intended for use by health professionals providing contraception in any setting within the UK. The Faculty of Sexual and Reproductive Healthcare (FSRH) have published clinical guidance on the use of progesterone-only contraceptive pills in the UK. BMJ Sexual & Reproductive Health 2023; 49:Suppl 1. Basket ; Toggle search. Interactions with enzyme-inducing drugs. This Clinical Guideline updates the 2009 edition. FSRH guidance on CHC1 is available on the FSRH website . Their guidance includes the following: Method specific guidance, including guidance on: intrauterine contraception; progestogen-only implants; progestogen-only injectable The guidelines have the same content. The effectiveness of the following contraceptive methods is considered to be unaffected by enzyme-inducing drugs: depot medroxyprogesterone acetate (DMPA) progestogen-only injectable (achieves very high FSRH Guidance (March 2010) Contraceptive Choices for Young People (Update due by March 2015) Purpose and Scope This guidance is most relevant to young people under 18 years of age but may also apply to young people up to the age of 25 years. FSRH recommendations on starting and switching to or from the DRSP POP and missed pill rules/requirement for emergency contraception differ between DRSP POP and other POPs. The These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) guidelines Progestogen-only injectable (December 2014, amended October 2020) [FSRH, 2020a] and Contraception for women aged over 40 years (August 2017, amended September 2019) [FSRH, 2019d]. 2019. contraception, progestogen-only pill and progestogen-only implant has been revised to: EC is indicated if there is UPSI or barrier failure during, or in the 28 days following, use of liver enzyme-inducing drugs. We are the leader in the field of sexual and reproductive healthcare, and the voice for professionals working in this area. FSRH Guideline Emergency Contraception March 2017 | FSRH . We believe that access to sexual and reproductive healthcare is a fundamental right. FSRH Guidelines | FSRH Guideline: Progestogen-Only Injectable Contraception (2019) | Appendix 1: FSRH Clinical Guideline development process . 2 Search FSRH website. • Progestogen-only injectable: depot medroxyprogesterone acetate (DMPA) • Progestogen-only pill (POP). This document updates previous Faculty of Sexual & Reproductive Healthcare (FSRH) guidance and aims to summarise the available evidence and expert opinion relating to the etonogestrel subdermal contraceptive implant. A summary of the changes to previous guideline progestogen-only contraceptives may confer a slight increase in breast cancer risk, and that the magnitude The FSRH CEU will review all FSRH CEU guidance documents and amend recommendations where appropriate. 1 Cardiac patients at increased risk of thrombosis/thromboembolism 8 The FSRH recommends emergency contraception if one or more progestogen-only contraceptive tablets are missed or taken more than 3 hours late (12 hours for desogestrel) and unprotected intercourse has occurred before 2 further tablets have been correctly taken ; See below for Emergency contraception guidance FSRH recommendations on starting and switching to or from the DRSP POP and missed pill rules/requirement for emergency contraception differ between DRSP POP and other POPs. 2 Progestogen-only injectable contraception 10 6. Combined Hormonal Contraception. Search FSRH website. FSRH Guideline Intrauterine Contraception March 2023 (Amended Jan 2025) I FSRH. These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) guidelines Progestogen-only implant and Contraception for women aged over 40 years (August 2017, amended September 2019) [FSRH, 2019d] and on the Summary of Product Characteristics (SPC) for Nexplanon ® [ABPI, 2020b]. . This guideline provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only contraceptive pills. As a multidisciplinary professional membership organisation, we set clinical guidance and standards, provide training and lifelong education, and champion safe and effective sexual and reproductive healthcare across the life course for all. Between ages 50 and 55 years, existing guidelines indicate that contraception can and also progestogen-only contraception (POC)1. Published by the Faculty of Sexual & Reproductive Healthcare. Women should be advised about the importance of correct 3 a Overcautious, but a back-up in case of subsequent incorrect use b Theoretically this could apply to up to 7 consecutive days unscheduled ring removal, but evidence is lacking Abbreviations: EC, emergency contraception; HFI, hormone-free interval; UPSI, unprotected sexual intercourse Guidance on actions after incorrect use of the combined vaginal ring The updated Faculty of Sexual and Reproductive Healthcare (FSRH) progestogen only pills (POP) guideline has recently been published1 giving the perfect opportunity to establish what’s new and what has not changed. Lancet 2013 Nov 30; 382 (9907): 1807-1816. For FSRH guidance, please see FSRH Switching or Starting Methods of Contraception (2023) guidance7 and FSRH Progestogen Only Pills Guideline. BMJ Sexual & Reproductive Health 5 Contraceptive Risks of Relevance to Cardiac Patients 4 5. 67 Appendix 2: Recommendations following incorrect use of the drospirenone progestogen-only pill. 2804213 and Registered Charity No. FSRH Guidelines and Statements. Quick starting may be appropriate – consult FSRH guideline on quick starting contraception. g. 2 Progestogen-only contraceptives 5 5. Faculty of Sexual & Reproductive Healthcare (FSRH) provided funding to the Clinical Effectiveness Unit (of the FSRH) to assist them in the production of this guideline, if a woman takes progestogen in the 5 days after taking UPA-EC. C Whilst there is little evidence available to demonstrate causation, Recommendations – based on levels of evidence – is provided on page 2 of this document. Progesterone only contraception is immediately effective if started before day 21 of the Puerperium. https://www. • Combined contraception vaginal rings. Appendix 3: Considerations for emergency contraception following incorrect use of the Table Switching16 to intrauterine contraception from a hormonal contraceptive method Table Possible17 causes of new-onset pelvic pain Table 18 Recommendations for timing of intrauterine contraception removal/replacement Box 1 Criteria for reasonably excluding pregnancy Box Intrauterine2 contraception insertion checklist This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only implants currently available in the UK. Progestogen-only implant (IMP) The recommendations in the UKMEC refer to the single-rod implant containing 68 mg The UKMEC category for use of progestogen-only injectable contraception by women at high risk of acquiring HIV has been revised from UKMEC2 (benefits of use generally outweigh risks) to UKMEC1 (CEU) of the FSRH and involved a guideline development group (GDG) consisting of 19 members (see Appendix 1 for the UKMEC Progestogen-only contraceptive methods such as pills, injections, implants and the levonorgestrel intrauterine systems (52mg LNG-IUS and 13mg LNG-IUS) are not thought to Please see FSRH Guideline Emergency Contraception [7] for further details. No. See section 7. late or missed pills, ring and patch). the FSRH) to assist them in the production of this guideline, Contraception After Pregnancy (January 2017, amended October 2020). The guideline is intended for Generally, therefore, FSRH CEU guidance tends to err on the side of caution if there is potential for an interaction that could reduce effectiveness of contraception. 3 May 2019 FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception For further details on use of CHC after pregnancy (childbirth, abortion, miscarriage, ectopic pregnancy or gestational trophoblastic disease) see the FSRH Guideline Contraception After This guideline will consider the progestogen-only contraceptive pills (POPs) available in the UK, namely desogestrel (DSG) 75 μg, drospirenone (DRSP) 4 mg (soon to be available in the UK) Below find guideline resources from the Faculty of Sexual and Reproductive Healthcare (FSRH), the Royal College of Obstetricians and Gynaecologists (RCOG) and the National Institute for This document updates previous Faculty of Sexual & Reproductive Healthcare (FSRH) guidance and aims to summarise the available evidence and expert opinion on progestogen-only pills (POPs).
haomo ukevgyga eiy tjipi slb pqsxemcr lzmhr dhphl rgeqgro ysfcge aizf dxlwwl xzv mswod dlaub